|2.26||-0.03 / -1.31%|
As of 3:59pm ET
|2.26||0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 4.15, with a high estimate of 5.50 and a low estimate of 3.00. The median estimate represents a +83.63% increase from the last price of 2.26.
The current consensus among 6 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.